Evidence map›Paper›PMID 35100614›Full record

Trial reportClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Stopping Hospital Infections With Environmental Services (SHINE): A Cluster-randomized Trial of Intensive Monitoring Methods for Terminal Room Cleaning on Rates of Multidrug-resistant Organisms in the Intensive Care Unit.

Matthew J Ziegler, Hilary H Babcock, Sharon F Welbel, David K Warren, William E Trick, Pam Tolomeo, Jacqueline Omorogbe, Diana Garcia, Tracy Habrock-Bach, Onofre Donceras and 11 more

Erratum issuedOpen access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 1 country.

Matthew J ZieglerDivision of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Hilary H BabcockDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.
Sharon F WelbelCook County Health, Chicago, Illinois, USA.
David K WarrenDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.
William E TrickCook County Health, Chicago, Illinois, USA.
Pam TolomeoCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Jacqueline OmorogbeCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Diana GarciaCook County Health, Chicago, Illinois, USA.
Tracy Habrock-BachDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.
Onofre DoncerasCook County Health, Chicago, Illinois, USA.
Steven GaynesHospital of the University of Pennsylvania, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.
Leigh CressmanCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Jason P BurnhamDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.
Warren BilkerDepartment of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Sujan C ReddyDivision of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
David PeguesDivision of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Ebbing LautenbachDivision of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Brendan J KellyDivision of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Barry FuchsDivision of Pulmonary Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Niels D MartinDepartment of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Jennifer H HanDivision of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
University of Pennsylvania · USWashington University in St. Louis · USCook County Health and Hospitals System · USCenters for Disease Control and Prevention · USRush University Medical Center · USUniversity of Pennsylvania Health System · US

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Impact of early gut microbiome features on risk of neutropenic fever and bloodstream infection in hematologic malignancyK23AI143925 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ZIEGLER, MATTHEW · 2020 to 2024
$975k
Longitudinal analysis of respiratory tract microbiome change and sequence-based infection diagnosis during mechanical ventilationK23AI121485 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI KELLY, BRENDAN JOSEPH · 2016 to 2020
$965k
CDC Epicenters for the Prevention of Healthcare Associated InfectionsNCATS NIH HHS UL1 TR002345NIAID NIH HHS K23 AI121485NIAID NIH HHS K23 AI143925NIAID NIH HHS L30 AI120149NIAID NIH HHS L30 AI147211
6 · The paper itself

Abstract

backgroundMultidrug-resistant organisms (MDROs) frequently contaminate hospital environments. We performed a multicenter, cluster-randomized, crossover trial of 2 methods for monitoring of terminal cleaning effectiveness.

methodsSix intensive care units (ICUs) at 3 medical centers received both interventions sequentially, in randomized order. Ten surfaces were surveyed each in 5 rooms weekly, after terminal cleaning, with adenosine triphosphate (ATP) monitoring or an ultraviolet fluorescent marker (UV/F). Results were delivered to environmental services staff in real time with failing surfaces recleaned. We measured monthly rates of MDRO infection or colonization, including methicillin-resistant Staphylococcus aureus, Clostridioides difficile, vancomycin-resistant Enterococcus, and MDR gram-negative bacilli (MDR-GNB) during a 12-month baseline period and sequential 6-month intervention periods, separated by a 2-month washout. Primary analysis compared only the randomized intervention periods, whereas secondary analysis included the baseline.

resultsThe ATP method was associated with a reduction in incidence rate of MDRO infection or colonization compared with the UV/F period (incidence rate ratio [IRR] 0.876; 95% confidence interval [CI], 0.807-0.951; P = .002). Including the baseline period, the ATP method was associated with reduced infection with MDROs (IRR 0.924; 95% CI, 0.855-0.998; P = .04), and MDR-GNB infection or colonization (IRR 0.856; 95% CI, 0.825-0.887; P < .001). The UV/F intervention was not associated with a statistically significant impact on these outcomes. Room turnaround time increased by a median of 1 minute with the ATP intervention and 4.5 minutes with UV/F compared with baseline.

conclusionsIntensive monitoring of ICU terminal room cleaning with an ATP modality is associated with a reduction of MDRO infection and colonization.

Indexed as

Cross InfectionMethicillin-Resistant Staphylococcus aureusVancomycin-Resistant EnterococciAdenosine TriphosphateDrug Resistance, Multiple, BacterialGram-Negative BacteriaHumansIntensive Care UnitsVancomycinAdenosine TriphosphateVancomycinbacterialcross infection/prevention & controlcross infection/transmissiondisinfectantsdrug resistanceintensive care unitsmultiple

Identifiers

PMID35100614
PMCPMC9525084
OpenAlexW4210723250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.